These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 29951978)

  • 1. Contribution of BHG and PPHG to Overall Hyperglycemia in T2DM Patients Treated with LM25 and LM50: Post Hoc Analysis of a Randomized Crossover Trial.
    Li W; Ping F; Xu L; Zhang H; Dong Y; Li H; Sun Q; Li Y
    Diabetes Ther; 2018 Aug; 9(4):1605-1614. PubMed ID: 29951978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Insulin Lispro Mix 25 and Insulin Lispro Mix 50 on Postprandial Glucose Excursion in Patients with Type 2 Diabetes: A Prospective, Open-Label, Randomized Clinical Trial.
    Li W; Ping F; Xu L; Zhou M; Li H; Dong Y; Li Y
    Diabetes Ther; 2018 Apr; 9(2):699-711. PubMed ID: 29520742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of LM25 and LM50 on Hypoglycemia in Chinese T2DM Patients: Post Hoc Analysis of a Randomized Crossover Trial.
    Li W; Ping F; Xu L; Zhang H; Dong Y; Yu K; Li Y
    Diabetes Ther; 2020 Mar; 11(3):643-654. PubMed ID: 31981211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of insulin lispro mix 25 with insulin lispro mix 50 as insulin starter in Chinese patients with type 2 diabetes mellitus (CLASSIFY study): Subgroup analysis of a Phase 4 open-label randomized trial.
    Su Q; Liu C; Zheng H; Zhu J; Li PF; Qian L; Yang WY
    J Diabetes; 2017 Jun; 9(6):575-585. PubMed ID: 27371341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of insulin lispro mix 25 with insulin lispro mix 50 as an insulin starter in Asian patients with type 2 diabetes: a phase 4, open-label, randomized trial (CLASSIFY study).
    Watada H; Su Q; Li PF; Iwamoto N; Qian L; Yang WY
    Diabetes Metab Res Rev; 2017 Jan; 33(1):. PubMed ID: 27155890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin lispro 25/75 and insulin lispro 50/50 as starter insulin in Japanese patients with type 2 diabetes: subanalysis of the CLASSIFY randomized trial.
    Watada H; Imori M; Li P; Iwamoto N
    Endocr J; 2017 Jul; 64(7):705-717. PubMed ID: 28539526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative Contribution of Fasting and Postprandial Blood Glucose in Overall Glycemic Control: Post Hoc Analysis of a Phase IV Randomized Trial.
    Su Q; Liu J; Li P; Qian L; Yang W
    Diabetes Ther; 2018 Jun; 9(3):987-999. PubMed ID: 29574635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of diet on the efficacy of insulin lispro mix 25 and insulin lispro mix 50 as starter insulin in East Asian patients with type 2 diabetes: Subgroup analysis of the Comparison Between Low Mixed Insulin and Mid Mixed Insulin as Starter Insulin For Patients with Type 2 Diabetes Mellitus (CLASSIFY Study) randomized trial.
    Chen W; Qian L; Watada H; Li PF; Iwamoto N; Imori M; Yang WY
    J Diabetes Investig; 2017 Jan; 8(1):75-83. PubMed ID: 27287069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin lispro low mixture twice daily vs basal insulin glargine once daily and prandial insulin lispro once daily as insulin intensification strategies in patients with type 2 diabetes: Latin American subpopulation analysis of a randomized trial.
    Rojas A; Sposetti G; Gross JL; Barbieri DE; Duan R; Linetzky B; De Lana JM; Stempa O; Rodriguez A
    Diabetol Metab Syndr; 2016; 8():69. PubMed ID: 27660663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of efficacy and safety of two starting insulin regimens in non-Asian, Asian Indian, and East Asian patients with type 2 diabetes: a post hoc analysis of the PARADIGM study.
    Ji L; Min KW; Oliveira J; Lew T; Duan R
    Diabetes Metab Syndr Obes; 2016; 9():243-9. PubMed ID: 27563254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative contributions of fasting and postprandial glucose increments, glycemic variability, and non-glycemic factors to HbA1c in individuals with type 1 diabetes.
    Zhou Y; Zheng M; Deng H; Zheng X; Luo S; Yang D; Mai X; Xu W; Yan J; Weng J
    J Diabetes; 2023 Jun; 15(6):465-473. PubMed ID: 37143431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.
    Ilag LL; Kerr L; Malone JK; Tan MH
    Clin Ther; 2007; 29 Spec No():1254-70. PubMed ID: 18046926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Efficacy and Economic Value of Prandilin 25 and Humalog Mix 25 in Patients with Newly Diagnosed Type 2 Diabetes by a Continuous Glucose Monitoring System.
    Luo Y; Wang XQ; Ni WJ; Ding B; Xu XH; Ye L; Ma JH; Zhu J
    Diabetes Ther; 2018 Dec; 9(6):2219-2228. PubMed ID: 30244319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Treatment Response to Insulin Intensification Therapy: A Post Hoc Analysis of a Randomized Trial Comparing Premixed and Basal-Bolus Insulin Regimens.
    Shi LX; Li PF; Hou JN
    Diabetes Ther; 2017 Aug; 8(4):915-928. PubMed ID: 28667381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EADSG Guidelines: Insulin Therapy in Diabetes.
    Silver B; Ramaiya K; Andrew SB; Fredrick O; Bajaj S; Kalra S; Charlotte BM; Claudine K; Makhoba A
    Diabetes Ther; 2018 Apr; 9(2):449-492. PubMed ID: 29508275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study comparing insulin lispro mix 25 with glargine plus lispro therapy in patients with Type 2 diabetes who have inadequate glycaemic control on oral anti-hyperglycaemic medication: results of the PARADIGM study.
    Bowering K; Reed VA; Felicio JS; Landry J; Ji L; Oliveira J
    Diabet Med; 2012 Sep; 29(9):e263-72. PubMed ID: 22672081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exenatide versus Insulin Lispro Added to Basal Insulin in a Subgroup of Korean Patients with Type 2 Diabetes Mellitus.
    Yoon KH; Hardy E; Han J
    Diabetes Metab J; 2017 Feb; 41(1):69-74. PubMed ID: 28029018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substantial Effects of Luseogliflozin Revealed by Analyzing Responses to Postprandial Hyperglycemia: Post Hoc Subanalyses of a Randomized Controlled Study.
    Samukawa Y; Omiya H; Watase H; Nozaki K; Sakai S; Nishimura R
    Adv Ther; 2016 Jul; 33(7):1215-30. PubMed ID: 27255763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Real-World Anti-Diabetes Medication Cost Comparison Between Premixed Insulin Analogs and Long-Acting Insulin Analogs in Chinese Patients with Type 2 Diabetes: A Retrospective Database Analysis.
    Gao Y; Wang K; Chen Y; Shen L; Hou J; Xuan J; Liu B
    Diabetes Ther; 2018 Apr; 9(2):673-682. PubMed ID: 29476413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.